Established in late 2022, CEO of Fluorobiotech Dr Anton Du Preez van Staden, a molecular biologist with over a decade of experience working in the fields of microbiology and recombinant protein expression, joined forces with Co-Founder and COO of Fluorobiotech, Ross Vermeulen. Together, they have combined their scientific expertise with a drive to create commercial value that can address the challenges faced by the biotech industry in South Africa.

In this episode, Brandon Paschal chats to the co-founders to understand how Fluorobiotech came to be, from research to commercialisation.

Subscribe for regular updates!